Integrating Epilepsy Performance Measures Into Clinical Practice

Slides:



Advertisements
Similar presentations
5S CLÍNICA MÉDICA (MH) 306 A. 5S CLÍNICA MÉDICA (MH) 306 B.
Advertisements

Group Music Integration Units Final Planning. Group Music Integration Units C.M. – Individual Behavioral Plan RD & MD (key of D) Guitar (A & D) p. 156.
Principles of Clinical Pathology Why do we Need to Study General Medical Issues?
Early Childhood Epilepsy Severity Scale (E-CHESS) Humphrey A et al. Epilepsy Research (2008) 79: 139— Frequency of seizures 2. Time period over.
The Nurse’s Role in Inflammatory Bowel Disease
PEOPLE’S CITY MISSION FREE MEDICAL CLINIC
Silent No More:.
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Primary Care Challenges in Depression - To Treat or Refer?
ICD-10 and Clinical Documentation
Pharmaceutical- vs Dispensary-Sourced Cannabinoids
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Does One Size Fit All in Obesity Management?
The Oncology Medical Home
At The Cutting Edge of Developments in the Management of Hyperkalemia
To Titrate or Not: Optimizing Treatment With Antiepileptic Drugs
Current Controversies in Multiple Sclerosis Management
Epilepsy Treatment Across the Spectrum
Epidemiology Venous Pathophysiology Etiology.
What Comes Second?.
Medication Nonadherence in Gout
Patient-Centered Care in Cystic Fibrosis
Case Challenges in Chronic Migraine
Definitions: Seizure, Epilepsy, Epilepsy Syndrome
Improving Diagnostic Accuracy in Epilepsy
Management Considerations in Epilepsy Among Long-Term Care Residents
Transition of Care in Epilepsy Among Patients Entering Long-Term Care
Successful Obesity Management and Counseling:
The Art and Science of Diagnosing Seizures
Treatment of Generalized Tonic-Clonic Seizures in the Modern Era
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
New Antiepileptic Drugs
New Antiepileptic Drugs
Updates in Neuronal Ceroid Lipofuscinosis
Steven Tobochnik, Camilo Gutierrez, Mercedes P. Jacobson 
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Seizures in the Elderly: Treatment and Special Considerations
Use of the Precaution Adoption Process Model to examine predictors of osteoprotective behavior in epilepsy  John O. Elliott, Brenda F. Seals, Mercedes.
Management of Adolescents With Seizures
Clinical Challenges in Epilepsy
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Managing Depression is a Team Effort:
EXAMINE Study: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome.
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Remote Patient Management:
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Diagnosing Focal Epilepsy: A Clinical Case
A Roadmap to Diagnosing the Next Patient With Hereditary Angioedema
Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.
Using Heart Rate as a Biomarker in Clinical Practice.
Program Goals. Technological Advances in Longer-Acting Factor Replacement Therapy for Hemophilia.
Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.
Steven Tobochnik, Camilo Gutierrez, Mercedes P. Jacobson 
Medication Risks for Older Drivers
Considerations in Managing Seizures in Women
Program Goals Disclaimers Defining Refractory Seizures.
Updates in Neuronal Ceroid Lipofuscinosis
Optimizing Management of Seizures Through Shared Decision Making
How Can Precision Medicine in Oncology Refine Best Treatment Approach?
Clinical Challenges and Updates in Managing Seizure Clusters
Program Goal. Program Goal Disclaimer Overview.
Selecting Treatment Approaches in Hemophilia
What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.
Issues in Patients With Severe Epilepsy
Binge Eating Disorder.
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Identifying TRK Fusions in Head and Neck Cancer
Acute and Chronic Seizures in Patients Older Than 60 Years
Clinical characteristics at diagnosis of brain metastases.
Presentation transcript:

Integrating Epilepsy Performance Measures Into Clinical Practice

Goals

Need for Performance Measures

Performance Measures -- Proposed

Performance Measures -- Adopted by CMS

Importance of Performance Measures: Etiology

Importance of Performance Measures: Seizure Frequency

Importance of Performance Measures: Teratogenicity of Seizure Medications

Other Performance Measures: Not Adopted -- Still Important

Other Performance Measures: Not Adopted -- Still Important (cont)

Other Performance Measures: Not Adopted -- Still Important (cont)

Other Performance Measures: Not Adopted -- Still Important (cont)

Applying Measures in Practice

Epilepsy Quality Measure Checklist

Abbreviations

References

References (cont)